Ipilimumab/pembrolizumabInflammatory polyarthritis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1735卷 / 1期

关键词：

D O I：

10.1007/s40278-019-56779-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：163 / 163

相关论文

共 50 条

[21] ThiamazoleMigratory polyarthritis: case report
Reactions Weekly, 2015, 1571 (1) : 228 - 228
[22] DurvalumabCarcinomatous polyarthritis: case report
Reactions Weekly, 2021, 1867 (1) : 168 - 168
[23] ClopidogrelAcute polyarthritis: case report
Reactions Weekly, 2014, 1529 (1) : 68 - 68
[24] Ipilimumab/sargramostimDermatomyositis: case report
Reactions Weekly, 2016, 1603 (1) : 158 - 158
[25] Ipilimumab/pembrolizumabIleus: case report
Reactions Weekly, 2023, 1956 (1) : 287 - 287
[26] Ipilimumab/NivolumabMyocarditis: case report
Reactions Weekly, 2024, 2028 (1) : 253 - 253
[27] Ipilimumab/nivolumabHypophysitis: case report
Reactions Weekly, 2022, 1887 (1) : 396 - 396
[28] Ipilimumab/nivolumabMyocarditis: case report
Reactions Weekly, 2021, 1854 (1) : 199 - 199
[29] Ipilimumab/nivolumabHepatitis: case report
Reactions Weekly, 2019, 1734 (1) : 292 - 292
[30] Ipilimumab/sintilimabAsthma: case report
Reactions Weekly, 2022, 1890 (1) : 143 - 143

← 1 2 3 4 5 →